Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Litemuppon Dec 01, 2016 10:55am

116 Views

Post# 25540061

Boiler room operations

Based on my experience and knowledge of Boiler room operations, they are done by more than 1 person located in a number of locations. I am seeing more folks here painting a negative picture versus a small number defending the stock and presenting info that is helpful. I think the Boiler room operation is coaxing investors to sell. Just my opinion.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!